Bilamellar Cationic Liposomes Protect Adenovectors from Preexisting Humoral Immune Responses
Open Access
- 1 March 2002
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 5 (3), 233-241
- https://doi.org/10.1006/mthe.2002.0545
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Cationic Liposome Conjugation to Recombinant Adenoviral Vector Reduces Viral AntigenicityJapanese Journal of Cancer Research, 2000
- EMAN: Semiautomated Software for High-Resolution Single-Particle ReconstructionsJournal of Structural Biology, 1999
- Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administrationGene Therapy, 1999
- Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4IgGene Therapy, 1998
- Cationic Liposomes Enhance Adenovirus Entry via a Pathway Independent of the Fiber Receptor andαv-IntegrinsHuman Gene Therapy, 1998
- Transient Immunosuppression with Deoxyspergualin Improves Longevity of Transgene Expression and Ability to Readminister Adenoviral Vector to the Mouse LungHuman Gene Therapy, 1997
- Complexes of Adenovirus with Polycationic Polymers and Cationic Lipids Increase the Efficiency of Gene Transfer in Vitro and in VivoJournal of Biological Chemistry, 1997
- Cystic Fibrosis Gene Therapy Using an Adenovirus Vector: In Vivo Safety and Efficacy in Nasal Epithelium. Howard Hughes Medical Institute, Iowa City, IAHuman Gene Therapy, 1994
- Vehicles for gene therapyNature, 1993
- Cryo-electron microscopy of vitrified specimensQuarterly Reviews of Biophysics, 1988